migraine medication Archives - CDR

Mayne Pharma releases Bupap generic

February 16, 2017 by Chain Drug Review butalbital acetaminophen tablets, generic version of Bupap, Mayne Pharma, migraine medication, Mikart, Scott Richards Pharmacy, Supplier News

GREENVILLE, N.C. — Mayne Pharma Inc. has launched butalbital acetaminophen tablets 50 mg/300 mg, a migraine medication, in the United States. Mayne said Thursday that it will distribute the product, a generic version of Bupap tablets (butalbital acetaminophen 50 mg/300 mg) from Valeant Pharmaceuticals International, on behalf of its partner Mikart Inc., the developer and

Eli Lilly to acquire CoLucid for $960 million

January 19, 2017 by Chain Drug Review acute treatment of migraine, CoLucid Pharmaceuticals, David Ricks, Eli Lilly, migraine medication, Thomas Mathers Business, Supplier News

INDIANAPOLIS — Eli Lilly and Co. plans to buy CoLucid Pharmaceuticals Inc., maker of a promising migraine medication, for about $960 million in cash. Cambridge, Mass.-based CoLucid is currently in development with lasmiditan tablets, indicated for acute treatment of migraine, and has completed the first of two Phase 3 trials. A data read-out for the